Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Eye Neoplasms
  • Melanoma
  • Mouth Neoplasms
  • Skin Neoplasms

abstract

  • The combination of temozolomide plus pegylated IFN-alpha-2b had antitumor activity and was well tolerated in patients with metastatic melanoma. Therefore, further study is warranted.

publication date

  • June 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21909

PubMed ID

  • 16639739

Additional Document Info

start page

  • 2445

end page

  • 51

volume

  • 106

number

  • 11